Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

Back to Top

Expert Meetings

The IPA Expert Meetings are groundbreaking invite-only events helping to advance the field in a particular area and issue. 

IPA Expert Meetings:

2019      Defining Neuropsychiatric Symptoms – Expert Consensus Meeting (Lisbon, Portugal)
Conveners:  Jeffrey Cummings, Mary Sano

2015      Behavioral and Psychological Symptoms of Dementia (BPSD) (Berlin, Germany)
Conveners:  Clive Ballard, Helen Kales, Constantine Lyketsos

2013      Agitation Definition Expert Consensus Meeting (Boston, United States)
Conveners:  Jeffrey Cummings, Jacobo Mintzer, Henry Brodaty, Mary Sano

2006      Defining and Measuring Treatment Benefits in Dementia (Canterbury, United
Conveners:  Edmond Chiu, Cornelius Katona, David Ames, and Gill Livingston

2005      MCI in the Elderly and Populations at Risk (Bethesda, United States)
Conveners: Karl Broich, Serge Gauthier, Ron Petersen, Barry Reisberg, Karen Ritchie

2003      Designing Therapeutic Trials for Agitation:  Developing Common Definitions, Tools, and Procedures (Lisbon, Portugal)
Conveners: Eric Caine, Glenn Currier, and Brian Lawlor

2002      Dementia with Lewy Bodies (Budapest, Hungary)
Conveners: Ian McKeith and Jacobo Mintzer

2001      Vascular Burden of the Brain: New Therapeutic Directions (Madrid, Spain)
Conveners: Timo Erkinjuntti, John T. O’Brien, and Barry Reisberg

1999      Behavioral and Psychological Symptoms of Dementia (BPSD):  A Clinical and Research Update (Landsdowne, United States)
Convener: Alistair Burns and Sanford Finkel

1996      Diagnosis of Alzheimer’s Disease (Geneva, Switzerland)

1996      Behavioral Disturbances of Dementia (Landsdowne, United States)
(Resulting publication – Behavioral and Psychological Signs and Symptoms of Dementia:  Implications for Research and Treatment)
Convener: Sanford Finkel

1994     Outcome Methodologies for Pharmacologic Trials in Mild, Moderate, and Severe
Alzheimer’s Disease (New York, United States)
Convener: Barry Reisberg

For more information about IPA Expert Meetings, please contact the IPA Secretariat –


Acadia Pharmaceuticals Avanir Pharmaceuticals Cambridge University Press